Fusion and SWE in hepatic and pancreatobiliary field
- Conditions
- Patients who have diseases in the pancreas or liver on contrast-enhanced CT scan or MRIPancreas/Liver
- Registration Number
- JPRN-jRCTs042190051
- Lead Sponsor
- Ishikawa Takuya
- Brief Summary
In the present study, the optimal number of shear wave elastography measurements for the pancreas was three. The obtained elastic modulus was significantly higher in pancreatic cancer than in normal pancreas. However, there was a large variation in the measured values in pancreatic cancer, and further study is warranted. Fusion of CT and ultrasound images can ensure objectivity in the local evaluation of pancreatic cancer. The Auto Registration function enables quick and accurate fusion.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 113
(1) Patients who have diseases in the pancreas or liver on contrast-enhanced CT scan or MRI and are planned to have transabdominal ultrasound.
(2) Patients over 20 years old at the time of enrollment.
(3) Preservation of main organ functions at the time of diagnosis.
(4) Provision of written consent to participate in the study.
(1) Uncontrollable infection including active tuberculosis
(2) Serious adverse events
(3) Severe mental disorder
(4) Patients with ascites
(4) Judgement as being ineligible by the principal or subinvestigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) To calculate the optimum condition (ROI size, analysis frame, artifact) to measure the shear wave elastography in the pancreas.<br>(2) Accuracy of the fusion between CT/MRI and ultrasound in the pancreas
- Secondary Outcome Measures
Name Time Method (1) Threshold between normal and abnormal and average value of the shear wave elastography in the pancreas<br>(2) Time required for the registration of fusion between CT/MRI and ultrasound